GSK executive acquires 9.43 notional ADS at $50.64

GSK plc reported that Maya Martinez-Davis, President, acquired notional American Depositary Shares through her GSK Executive Supplemental Savings Plan account.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

GSK plc reported that Maya Martinez-Davis, President, acquired notional American Depositary Shares through her GSK Executive Supplemental Savings Plan account. The transaction involved 9.4289 ADS at a price of $50.6400 per ADS on 2026-06-08, executed on the New York Stock Exchange.

Key Figures

ADS volume acquired: 9.4289 ADS ADS price: $50.6400 per ADS Transaction date: 2026-06-08 +1 more

4 metrics

ADS volume acquired 9.4289 ADS Notional ADS in Executive Supplemental Savings Plan

ADS price $50.6400 per ADS Acquisition price on 2026-06-08

Transaction date 2026-06-08 Date of notional ADS acquisition

Instrument ISIN US37733W2044 American Depositary Shares

Key Terms

American Depositary Shares, Executive Supplemental Savings Plan, PDMR, LEI

4 terms

American Depositary Shares financial

"Description of the financial instrument | American Depositary Shares ('ADS') ISIN: US37733W2044"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Executive Supplemental Savings Plan financial

"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account"

PDMR regulatory

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

LEI regulatory

"Name | GSK plc b) | LEI | 5493000HZTVUYLO1D793"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GSK (GSK) disclose in this Form 6-K?

GSK disclosed that President Maya Martinez-Davis acquired notional American Depositary Shares through her GSK Executive Supplemental Savings Plan account. The single transaction occurred on 2026-06-08 and was reported as an acquisition of notional ADS rather than a direct market trade.

How many ADS did Maya Martinez-Davis acquire according to the GSK (GSK) filing?

Maya Martinez-Davis acquired 9.4289 notional American Depositary Shares in her GSK Executive Supplemental Savings Plan account. The transaction was reported as a single event with aggregated information marked as not applicable, reflecting a relatively small plan-related position adjustment.

At what price were the GSK (GSK) ADS acquired in the reported transaction?

The notional American Depositary Shares were acquired at a price of $50.6400 per ADS. This price applies to the 9.4289 ADS credited within the GSK Executive Supplemental Savings Plan account for President Maya Martinez-Davis as disclosed in the Form 6-K report.

When did the reported GSK (GSK) insider transaction take place?

The transaction took place on 2026-06-08. On that date, notional American Depositary Shares were acquired within President Maya Martinez-Davis’s GSK Executive Supplemental Savings Plan account, and the activity was subsequently disclosed in a Form 6-K report for transparency purposes.

Where were the GSK (GSK) ADS associated with this transaction listed?

The American Depositary Shares involved in the transaction are listed on the New York Stock Exchange, identified as XNYS. The filing specifies that the acquisition of notional ADS within the plan account relates to securities traded on this U.S. exchange.

What type of instrument was involved in the GSK (GSK) PDMR transaction?

The instrument was American Depositary Shares, described with ISIN US37733W2044 in the report. These ADS represent GSK equity for trading on U.S. markets, and the filing clarifies that notional ADS were acquired within the executive supplemental savings plan account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/10/2026 - 10:36 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Maya Martinez-Davis
b)	Position/status	President, US
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADS') ISIN: US37733W2044
b)	Nature of the transaction	Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		$50.6400	9.4289
d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2026-06-08
f)	Place of the transaction	New York Stock Exchange (XNYS)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GSK plc
	(Registrant)

Date: June 10, 2026

	By:/s/ VICTORIA WHYTE --------------------------

	Victoria Whyte
	Authorised Signatory for and on
	behalf of GSK plc

Source: View Original Filing on SEC EDGAR